Danazol (Azol)

Subscribe to Selected New Research on Danazol

1110 relevant articles (151 outcomes, 154 trials/studies) found for this Drug

Description: A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.

Also Known As:

Azol; Danocrine; Alphapharm Brand of Danazol; Antigen Brand of Danazol; Cyclomen; Danatrol; Danazant; Danazol-ratiopharm; Danol; Danoval; Kendrick Brand of Danazol; Ladogal; Norciden; Panacrine; Sanofi Brand of Danazol; Sanofi Synthelabo Brand of Danazol; Sanofi Winthrop Brand of Danazol; ratiopharm Brand of Danazol; Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol, (17alpha)-

Relationship Network

Drug Context: Research Results

Polycyclic Compounds: 59

17-hydroxy-2-(hydroxymethyl)-17-pregn-4-en-20-yn-3-one

17-hydroxy-2-(hydroxymethyl)-17-pregna-1,4-dien-20-yn-3-one

21-chloro-6-dehydrodanazol

21-chlorodanazol

isodanazol

Experts

1.	Farquhar, C: 3 articles (01/2007 - 01/2000)
2.	Selak, V: 3 articles (01/2007 - 01/2000)
3.	Singla, A: 3 articles (01/2007 - 01/2000)
4.	Prentice, A: 3 articles (01/2007 - 01/2000)
5.	Neonaki, M A: 3 articles (04/2001 - 06/2000)
6.	Matalliotakis, I M: 3 articles (04/2001 - 06/2000)
7.	Koumantakis, E E: 3 articles (04/2001 - 06/2000)
8.	Goumenou, A G: 3 articles (04/2001 - 06/2000)
9.	Ishihara, Hiroaki: 2 articles (06/2008 - 03/2003)
10.	Honjo, Hideo: 2 articles (06/2008 - 03/2003)

Related Diseases

1.	Endometriosis (Adenomyosis) 03/01/1989 - "Although the high pretreatment level of serum CA 125 decreased after danazol treatment of 400 mg/day to within the normal limits, usually within 4 to 12 weeks, laparoscopic examinations indicated that most of the endometriosis cases were not cured until 12-16 weeks of danazol treatment." 01/01/1979 - "Based on "second look" pelviscopic control in 438 cases of pelvic endometrosis, additional hormonal antigonadotrophin therapy with danazol represents the most effective treatment for endometriosis. " 07/01/1976 - "Nineteen of the 40 patients in the study had a secondary diagnosis of pelvic endometriosis confirmed histologically, and all these patients showed a marked improvement of symptoms during the Danazol treatment. " 12/01/1975 - "Danazol therapy was found to be very effective in this study for the treatment of pelvic endometriosis, and the drug was well tolerated by the patients." 10/15/1981 - "The results of large clinical studies suggest that danazol treatment produces significant improvement in the symptoms, signs, and laparoscopic findings of endometriosis. " Order ALL the reference details at left...
2.	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/01/1987 - "Although danazol is effective in the treatment of idiopathic thrombocytopenic purpura, its long-term safety and optimal dosage are not well established. " 03/01/1987 - "Thus, danazol appears to be an effective immune modulator, correcting the abnormality of T-cell subsets seen in autoimmune thrombocytopenia by increasing the percentage of Thi lymphocytes." 06/01/1992 - "Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy." 11/01/1989 - "Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women." 05/01/1985 - "Use of danazol in the management of chronic idiopathic thrombocytopenic purpura." Order ALL the reference details at left...
3.	Hereditary Angioedema 01/01/1988 - "A 24-year-old woman, having familial hereditary angioneurotic edema (HAE) treated with danazol, developed an anti-Ro-positive lupus featured by a mild erythematous eruption that seemed initially to decrease and then worsened under danazol, and dramatically improved after danazol was withdrawn. " 05/01/1980 - "Danazol is an effective agent for the prophylaxis of the recurrent attacks of mucocutaneous and visceral swelling which occur in patients with hereditary angioedema (HAE). " 04/01/1979 - "Danazol, an attentuated androgen, has been suggested as an effective agent for the prophylaxis of attacks of hereditary angioedema. " 04/01/1999 - "PURPOSE: This study evaluated the efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial or dental procedures. " 04/01/1999 - "The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures." Order ALL the reference details at left...
4.	Pain (Aches) 06/01/1982 - " The use of a newsteroidal agent, danazol, on a 3-6 month trial of 100-400 mg/day will eliminate pain and nodosities in some 69% of women and in another 30% the signs and symptoms will be diminished." 01/01/1979 - "The preliminary results of a double-blind randomized cross-over trial of danazol versus placebo in patients with severe cyclical breast pain are reported. " 01/01/2009 - "For lumbosacral pain, rectal discomfort, or vaginal nodules tenderness, there was no significant difference either between CHM and danazol. " 10/01/2007 - "Danazol produced a significant benefit with a mean pain score difference -20.23(95% CI -28.12 to -12.34). " 11/01/2004 - "INTRODUCTION: Ten percent of women present with moderate to severe mastalgia, and danazol achieves pain relief control with variable results. " Order ALL the reference details at left...
5.	Angioedema 05/01/2002 - "The danazol treatment relieved the symptoms of angioedema and increased the C1 INH activity and concentration with the normalization of CH50, C1q and C4 levels. " 04/01/1990 - "She responded well to danazol and had no further attacks of angioedema." 05/01/2004 - "Because of the danger of angioedema that might be expected following chemo-radiotherapy, he was treated with danazol. " 11/01/2003 - "The angioedema was controlled with Danazol and Stanasol. " 06/01/2003 - "The angioedema was controlled with Danazol and Stanasol. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Gonadotropin-Releasing Hormone (GnRH)
2.	Leuprolide (Lupron)
3.	Gestrinone
4.	Nafarelin (Synarel)
5.	Danazol (Azol)
6.	Inosine Triphosphate (ITP)
7.	Hormones
8.	Progestins (Progestagens)
9.	Estrogens (Estrogen)
10.	Prednisone (Sone)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Intrauterine Devices (Intrauterine Device)
3.	Ovariectomy (Oophorectomy)
4.	Splenectomy
5.	Plasma Exchange

Best Treatments:
Research Summary Report
on Endometriosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 382 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>